|
|
||||||||
Articles |
1
Dipartimento di Biochimica e Biotecnologie Mediche and CEINGE scarl,
2
Cattedra di Gastroenterologia, Facoltà di Medicina e Chirurgia, Università di Napoli "Federico II", I-80131 Naples, Italy.
3
Cattedra di Gastroenterologia, Seconda Università
di Napoli, I-80131 Naples, Italy.
4
Facoltà di Scienze Matematiche, Fisiche e
Naturali, Università del Molise, I-86170 Isernia, Italy.
a Address correspondence to this author at: Dipartimento di Biochimica e Biotecnologie Mediche, via S. Pansini 5, I-80131 Naples, Italy. Fax 39-081-7463650; e-mail salvator{at}unina.it
Background: Chronic liver diseases can progress to cirrhosis and to hepatocellular carcinoma. Timely and unequivocal recognition of the neoplastic evolution of cirrhosis is critical. To this aim, we used a noncompetitive reverse transcription-PCR procedure to analyze aldolase A mRNA in liver tissue from patients with chronic liver diseases at different stages.
Methods: We studied 12 patients with hepatocellular carcinoma, 19 patients affected by chronic hepatitis C or cirrhosis, and 7 healthy controls. Aldolase A mRNA was reverse-transcribed to cDNA, which was then amplified by PCR. The amplified segments were "read" with a novel dot-blot procedure. A calibrator with the same sequence, synthesized in vitro using a T7 phage promoter, was processed at scalar dilutions in parallel to the target samples to generate a calibration curve and so quantify the target mRNA (detection limit, 0.03 amol; linearity spanning five orders of magnitude).
Results: Aldolase A mRNA was ~10-fold higher in liver biopsies from patients with hepatocellular carcinoma vs patients with chronic hepatitis C or cirrhosis, and healthy individuals. Furthermore, aldolase A mRNA concentrations were 1.2- to 21.3-fold higher in 12 liver biopsies compared with the paired surrounding cirrhotic tissue.
Conclusions: The quantitative analysis of liver tissue aldolase A mRNA differentiates between nonneoplastic chronic liver diseases and hepatocellular carcinoma, which suggests that it has diagnostic potential.
The following articles in journals at HighWire Press have cited this article:
![]() |
G. Castaldo, R. Tomaiuolo, A. Sanduzzi, A. Ponticiello, I. Marchetiello, and F. Salvatore Carcinoembryonic antigen mRNA analysis detects micrometastatic cells in blood from lung cancer patients Eur. Respir. J., September 1, 2003; 22(3): 418 - 421. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |